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Abstract: As life expectancy in people living with HIV (PLWH) has increased, the focus of management
has shifted to preventing and treating chronic illnesses, but few services exist for the assessment
and management of these individuals. Here, we provide an initial description of a geriatric service
for people living with HIV and present data from a service evaluation undertaken in the clinic. We
conducted an evaluation of the first 52 patients seen in the clinic between 2016 and 2019. We present
patient demographic data, assessment outcomes, diagnoses given, and interventions delivered to those
seen in the clinic. The average age of attendees was 67. Primary reasons for referral to the clinic included
management of complex comorbidities, polypharmacy, and suspected geriatric syndrome (falls, frailty,
poor mobility, or cognitive decline). The median (range) number of comorbidities and comedications
(non-antiretrovirals) was 7 (2–19) and 9 (1–15), respectively. All attendees had an undetectable viral
load. Geriatric syndromes were observed in 26 (50%) patients reviewed in the clinic, with frailty
and mental health disease being the most common syndromes. Interventions offered to patients
included combination antiretroviral therapy modification, further health investigations, signposting
to rehabilitation or social care services, and in-clinic advice. High levels of acceptability among
patients and healthcare professionals were reported. The evaluation suggests that specialist geriatric
HIV services might play a role in the management of older people with HIV with geriatric syndromes.
Keywords: HIV; geriatrics; comprehensive geriatric assessment
1. Introduction
Increased life expectancy in people living with HIV (PLWH) has brought the challenges of ageing
and age-related issues to HIV clinical care [1]. In the UK, 39% of those accessing HIV services are
now aged 50 and over, representing over 36,000 individuals considered “older” with HIV [2]. Cohort
ageing is set to continue, with modelling work based on PLWH in the Netherlands predicting that,
by 2030, 73% will be aged over 50 [3]. Importantly, as PLWH grow older, they appear to be experiencing
disproportionally more age-related comorbidities than age-matched HIV-negative populations [4–6].
This is accompanied by greater polypharmacy, as well as issues of functional and cognitive decline,
frailty, and falls [7,8]. These issues may be grouped as “geriatric syndromes”, highlighting a role for
geriatric/elderly medicine within current HIV care [8–10].
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How best to deliver geriatric care to PLWH remains unclear. Some service providers advocate for
dedicated HIV-ageing services, and a small number of such services have developed or are developing
around the world [11]. Joint HIV/speciality clinics have been effective within other specialties [12,13],
therefore opening the door to the possibility of HIV-ageing clinics. However, outside of single-organ
specialties, the clinical need and criteria for referral are harder to define. One approach is to clinically
assess patients at a set age, such as 50 [14], though with the median age of HIV services users in
the UK at 46, demand may be excessively high. An alternative could be the use of frailty or frailty
syndromes in a “needs-based approach”. Tools to identify patients at risk of frailty using scoring
methods are increasingly used internationally and have recently been integrated into UK primary
care [15]. In October 2019, the European AIDS Clinical Society (EACS) published the first HIV guidance
that advocates for frailty screening in older PLWH.
Frailty represents a reduction in physiological reserve that makes one vulnerable to adverse health
outcomes [16]. It is prevalent in PLWH and has been associated with falls, incident multi-morbidity,
hospitalisation, and death [17–19]. Frailty may present non-specifically (fatigue, weight loss) or as
frailty syndromes such as falls, functional decline, and immobility. Additionally, frailty may contribute
to medical complexity (polypharmacy and multi-morbidity) and has been associated with low mood
and cognitive decline [20,21]. The recommended approach to the assessment and management of
frailty is through Comprehensive Geriatric Assessment (CGA) [22]. Proactive identification of frailty
and the introduction of CGA can enable early intervention to help PLWH to remain independent. CGA
is a multidimensional, interdisciplinary diagnostic process used to determine the medical, psychosocial,
and functional capabilities of older adults. Evidence suggests that CGA-based care can improve
functional capacity and reduce the risk of institutionalisation when applied to other chronic conditions
such as cancer, renal disease, and cardiovascular disease [23–25].
Older PLWH may face a complicated healthcare landscape [26], with HIV-specific management
falling down the list of health priorities in favour of age-related issues, which HIV services may be
ill-equipped to deal with due to lack of time, resources, or geriatric expertise.
In order to address the issues facing this ageing cohort, the Silver Clinic was established in the
Brighton and Sussex University Hospitals Trust. This multi-disciplinary HIV-ageing clinic utilises a
CGA approach to assess and manage age-related problems in PLWH. This paper aims to describe the
service and results of an initial service evaluation of the clinic.
2. Methods
The Silver Clinic team consists of an (i) HIV consultant physician, (ii) Geriatrics consultant
physician, (iii) HIV nurse specialist, and (iv) HIV pharmacist. The clinic operates monthly within
the HIV outpatient (Lawson) unit. Clinic referrals come from any HIV healthcare professional (HCP)
involved in the care of the patient. The Silver Clinic team is blinded to the process of referral. Current
referral criteria are age (>50 years), presence of complex comorbidities and/or polypharmacy, or geriatric
syndromes including frailty, falls, and difficulties with activities of daily living. All patients attending
the clinic up until October 2019 were included in this evaluation. No exclusion criteria were applied.
As this was a service evaluation, ethical approval was not obtained following assessment by the UK
Health Research Authority (http://www.hra-decisiontools.org.uk/research/). Written inform consent
was provided for the case study.
2.1. Clinic Process
Before attending, new patients are asked to complete a number of screening questionnaires focussed
around physical, functional, mood, and cognitive status. The questionnaires are patient-reported
outcome measure (PROM) tools that serve two purposes. Firstly, they help practitioners to identify
medical, social, or mental health issues that patients have before they are seen in the clinic. Secondly,
they can be used to monitor the impact of the service. Prior to first clinic attendance, a multidisciplinary
case-based discussion of each patient is organised. This includes: background and PROM review,
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evaluation of current clinical problems, and anticipated need of further investigations. All patients then
receive a dual consultation with the HIV and elderly medicine physician focused on CGA. This explores
patient demographics; social characteristics; comorbidity (including medications); functional, physical,
mental health, and frailty status (Table 1). All assessments are triangulated by the multidisciplinary
(MDT) to generate a comprehensive individualised management plan that is overseen by the Silver
Clinic team and communicated to the referring clinician and the GP where the patient consents.
The clinic process for the service is shown in Figure 1.
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Table 1. Clinical assessments performed within the Silver Clinic.
Test Category
Blood Tests Calcium, TFTs, PSA, HbA1c, B12/Folate, Vitamin D
HIV clinical data Year of diagnosis, nadir and current CD4 cell count, currentCD8 cell count, CD4:CD8 ratio, antiretroviral history
Other clinical data Urinalysis, height, weight, body mass index, blood pressure(lying and standing)
Mood assessment Hospital Anxiety and Depression Scale
Frailty assessment FRAIL scale
Patient reported outcome measures Euroqol-5D-5LOlder Peoples’ Quality of Life Questionnaire
TFTs, thyroid function tests; PSA, prostate-specific antigens; HbA1c, Haemoglobin A1c.
2.2. Clinical Assessments
Clinical data are drawn from patient notes and most recent routine HIV health checks. Baseline
observations, including postural blood pressure and body mass index (BMI), are performed. Blood
tests are taken to exclude issues contributing to age-related comorbidities, including vitamin B12 and
folate deficiency, associated with neuropsychiatric issues, depression, and demyelinating myelopathy;
calcium and 25-OH-Vitamin-D for bone health, falls, and mobility. The full assessment strategy is
shown in Error! Reference source not found.
Mood symptoms are assessed using the Hospital Anxiety and Depression Scale (HADS),
a short, self-report screening questionnaire for generalised anxiety and depression among patients
in non-psychiatric settings. The questionnaire is split into two sub-scales for anxiety (HADS-A) and
depression (HADS-D), in which a score ≥11 is considered diagnostic [27].
Patient-reported outcome measures (PROM) include the Older Peoples’ Quality of Life
Questionnaire (OPQL-brief), a 13-item validated tool for assessing quality of life (QoL) in older
people. Scores range from 13 to 65, indicating lowest to highest QoL [28,29]. EuroQol five-dimension
descriptive system (EQ-5D-5L) is a brief self-reported measure of generic health and perceived health
status that has been used across a number of health conditions and populations [30,31]. The tool
includes a visual analogue scale on which individuals indicate their current health state in relation to
best and worst imaginable health (100–0, respectively). FRAIL Scale is a clinical screening tool for the
identification of frailty. It comprises five self-reported components of fatigue—resistance, ambulation,
illnesses, and weight loss—which are scored as present or absent, resulting in a score from 0 to 5.
Those scoring 0 are robust, 1–2 prefrail and ≥3 frail [32].
Changes in scores for EQ-5D-5L and OPQL-brief and FRAIL scale at baseline (first assessment)
and discharge (12 months) were calculated.
2.3. Patient and Healthcare Professional Satisfaction
A voluntary self-completed survey was completed by patients after the clinic appointment.
The survey asked patients to provide qualitative “free-text” feedback of the service, including whether
and how it benefitted them and suggestions for service improvement.
An 8-question online questionnaire for healthcare professionals, excluding those working in the
Silver Clinic, was accessible from January to March 2018. This was created and hosted using Bristol
Online Surveys and distributed via email to all HIV staff. Job role, clinic awareness and referral
experience, perceived importance of the clinic, and improvement to older PLWH care were assessed.
Partially completed questionnaires were omitted from analysis.
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2.4. Statistical Analysis
Descriptive statistics using frequency, mean, or median with respective corresponding percentages,
standard deviation, and interquartile range were used to summarize the data. Paired sample t-tests
were used to evaluate the impact of the Silver Clinic intervention on scores for each PROM (EQ-5D-5L
and OPQL-brief and FRAIL scale) from baseline to discharge from the clinic. A framework method of
analysis was employed for qualitative data, with frequencies and percentages reported for qualitative
variables where grouping was possible [33].
3. Results
From January 2015 to October 2019, the Silver clinic assessed 52 patients. Demographic
characteristics, HIV, and other clinical data of clinic attendees are presented in Table 2. The median
(range) age of attendees was 67 years (53–87), and the majority were white males identifying as men
that have sex with men (MSM), reflecting the clinic population. Attendees had well-controlled chronic
HIV, with 100% virally suppressed. Primary referral reason for patients attending the clinic was 67%
(35) multimorbidity optimisation, 13% (7) problematic polypharmacy, and 17% (10) suspected geriatric
syndrome (falls, frailty, mobility issues, cognitive decline).
Table 2. Summary of patient characteristics.
Clinical Characteristics (n = 52) Median (IQR) Otherwise Stated
Age (years) 67 (53–87)
Male, n (%) 47 (90)
White ethnicity, n (%) 50 (96)
Identified sexuality, n (%)
MSM 41 (78)
Heterosexual 9 (17)
Other 2 (4)
Current smoker, n (%) 17 (32)
Alcohol use, n (%)
Less than 10 units per week 41(77)
Between 10 and 20 units per week 5 (9)
>20 units per week 3 (4)
Recreational drug use n (%) 6 (11)
Comorbidities 7 (2–19)
Comedications 9 (1–15)
QRISK3 * 25 (6–52)
Bone densitometry, n (%)
Osteoporosis 15 (28)
Osteopenia 33 (63)
Normal BMD 4 (7)
HIV Clinical Parameters
Time since HIV diagnosis: years (median; range) 17 (6–34)
Duration of cART: years (median; range) 17 (5–30)
cART-based regimen n (%)
Protease inhibitor 28 (53)
NNRTI 12 (23)
INSTI 12 (23)
HIV RNA < 50 copies/mL, n (%) 52 (100)
Nadir CD4 (cells/µL) 287 (223)
Current CD4 (cells/µL) 563 (368)
CD4:CD8 ratio 0.60 (0.1)
MSM, men who have sex with men; cART, antiretroviral therapy; QRISK®3-2018 cardiovascular risk calculator.
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Geriatric syndromes were observed in all patients reviewed in the clinic, with frailty and mental
health disease being the most common syndromes, as shown in Figure 2. Patients had a median (IQR)
of 7 (2–19) comorbidities. Cardiovascular disease was the most common, reported by 36 patients
(70%), followed by neurological disorder (63%), chronic pain syndrome (44%), and mental health
conditions (42%). Polypharmacy defined as more than five non-antiretroviral drugs was common,
with a median of nine (1–15) medications in addition to their ARVs. The most common comedications
at first assessment were cardiovascular medications, followed by analgesics (61%), mental health drugs
(40%), and supplements such as vitamins, etc. (53%). Notably, 30% were taking opioid medications for
pain and 19% taking benzodiazepines to manage insomnia.
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3.1. Patient-Reported Outcomes
Perceived health-related QoL at first assessment was poor on both the EQ-5D-5L and OPQOL,
with mean scores (SD) for the visual scale on the EQ-5D-5L 56.76 (21.2) and 32.76 (8.48) for the OPQOL,
respectively. Thirty-four (65%) patients were classified as frail; 14 (26%) were deemed prefrail and 4 (4%)
robust using the FRAIL scale. Mental health was assessed using the HADS: 46% (23) had depression or
anxiety symptoms at first assessment. No significant changes in EQ-5D-5L and OPQOL-Brief scores
were observed at discharge compared to baseline (p = 0.885 and p = 0.218, respectively). Moreover,
no changes in frailty status were observed at discharge using the FRAIL scale (p = 0.495)
3.2. Clinic Outcomes
At the point of data analysis, most patients had attended the clinic at least twice, with the median
number of visits being two (2–8). The greatest number of visits was eight (two patients). ARV
switch recommendations were made in six patients ue to toxicities or drug–drug interactions (DDI).
Twenty-seven specialist referrals were made, including to the broader multidisciplinary team including
physi therapy and occupational therapy. The clinic has now discharged 42 patients, 4 await f llow-up
appointment and 6 patients remain open to the service “as eeded.
Case Study
To better understand that type of patients we see in the service we described the case of Mr X,
a 69-year-old male who was diagnosed with HIV in 1999. He attended the Silver Clinic with complaints
of feeling “f d up” and intermittent faecal inco tinence. He has mult ple comorbidities with associated
polyph rmacy, as shown in Table 3. He is an ex-smoker who dri ks less than 4 units/ eek, with no
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recreational drug use. He lives alone and reports feeling socially isolated. He has poor mobility but
dislikes using a recommended walking stick and reports three falls during the last 3 months. He relies
heavily on his car as he lives in a rural village. His social benefits were reduced last year. His HIV is
well controlled, with a current CD4 count of 750 cell/mL and undetectable viral load on a regimen of
Darunavir, Ritonavir, and Lamivudine (3TC). His Q-Risk score was 16.5%.
Table 3. Mr X comorbidities and medications.
Medical Comorbidities Comedications
Type 2 diabetes
Depression
Osteopenia
Dyslipidaemia
Chronic back pain secondary to (degenerative disease
and C-spine injury)
Peripheral neuropathy (ART-related)
Chronic inflammatory demyelinating
polyneuropathy unresponsive to immunoglobulin
1. Paroxetine 40 mg daily
2. Gabapentin 400 mg twice daily
3. Aspirin 75 mg daily
4. Zopiclone 7.5 mg at night
5. Pravastatin 10 mg at night
6. Zomorph MR 60 mg twice daily
7. Metformin 1 g twice daily
8. Folic Acid 5 mg daily
9. Oramorph 5−10 mg as needed
1. Proactive treatment of constipation (causing overflow incontinence) and opioid reduction.
2. Fall prevention through occupational and physiotherapy referral and bone scan with subsequent
osteoporosis treatment to reduce fracture risk.
3. Medicines rationalisation with ART modification to a one tablet regimen (Rezolsta:
Darunavir/Cobistat), which in turn allowed Zopiclone withdrawal.
4. Signposting to community peer services aimed at increasing socialisation and an application for a
disabled parking “Blue Badge” was supported.
5. Referral to Cognitive Behavioural Therapy with the hope that improvements in mental health
may also stem from comorbidity optimisation.
At follow-up, despite subjectively his symptoms persisting, QOL based on the EQ-5D-5L and
OPQOL had improved.
3.3. Patient Satisfaction
All patients were asked to provide their views of the clinic. Fourteen responses (35%) were
received, with 13 (93%) stating that they were “very satisfied” with the service they received, and one
respondent was “somewhat satisfied”. Qualitative feedback themes identified among respondents were
“friendliness/kindness” (28%), “felt listened to” (14%), professional/helpful service (43%). Additional
comments referred to the opportunity for in-depth explanation and care coordination.
3.4. Healthcare Professionals’ Views of the Silver Clinic
Fourteen (63%) staff responded to our invitation to provide views on the clinic; this included
six (43%) doctors, six (43%) nurses, and two (14%) pharmacists. All participants were aware of the
clinic, and six (42%) had made referrals. Twelve (85%) believed the Silver Clinic was “very important”
for the management of older PLWH and the other two (14%) believed it was “quite important”.
All respondents felt that the clinic improved the management of older PLWH.
4. Discussion
HIV services have a history of being proactive in their innovation of care models to address
the changing needs of their patients. Clear trajectories towards HIV cohort ageing exists in the UK
with accompanying age-related medical and psychosocial issues [34]. The Silver Clinic was created
to address this emerging need—by employing multidisciplinary working and principles of geriatric
care, it has sought to improve the care management of this complex cohort. This service evaluation
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demonstrates that the average age of Silver Clinic attendees was 67 years old, with the majority referred
for management of multimorbidity, polypharmacy, and geriatric/frailty syndromes, which one might
anticipate within general elderly medical services.
Classical geriatric syndromes have been demonstrated in older adults, with HIV at higher
frequency and earlier age than one might expect for the general population. In one US study of
155 PLWH, median age 57, the prevalence of falls was 26%, and 54% described two or more geriatric
syndromes, which were associated with greater comorbidity and lower nadir CD4 count [8]. In our
clinic, cohort geriatric syndromes were common, with 44% complaining of mobility issues and 30%
experiencing falls. These may be linked to other observed findings of mood disorder in 45% and social
isolation in 9%. Social isolation was shown to be more common in older adults with HIV compared to
those without (59% vs. 51%, p < 0.001) in the Veterans Aging Cohort Study and was associated with
increased hospitalisation and mortality [35].
The majority of clinic attendees were frail (65%) based on the FRAIL scale, with a further 26%
deemed prefrail. This is considerably higher than frailty prevalence seen in previous studies of PLWH,
where frailty based on the Fried Phenotype (FP) ranged from 3 to 28% [36]; using this same measure,
prevalence was 3% for frailty and 38% prefrailty in a large UK community study of adults aged
37–73 years [37]. The larger proportion with frailty in our group is reflective of the service model and
its remit as a needs-based service, with frailty syndromes within the referral criteria. Targeting of frail
and prefrail individuals is vital, however, as both are associated with an increased risk of incident
disability in both personal and instrumental activities of daily living and mortality compared to robust
individuals [32,38]. Though the natural trajectory of frailty is progressive, studies have demonstrated
stability in frail state at one year, as was demonstrated in this non-interventional evaluation of the
service [39]. The ongoing presence of frailty in this selected cohort suggests that they may have the
most to gain from ongoing geriatric medical input.
The clinic users had a high burden of comorbidity and polypharmacy, particularly mood
disorder (45%) and chronic pain, with 30% on regular opiates. High levels of comorbidity and
polypharmacy have been noted in cohorts of PLWH [14,40], with both related to greater duration
of HIV rather than older age [40]. Chronic opiate use for non-cancer pain is higher in PLWH and
is associated with greater comorbidity, and it is an independent risk factor for falls, along with
other medications such as benzodiazepines, in this group [41,42]. Comorbidity and polypharmacy,
including chronic pain, combined with both frailty and broader geriatric syndromes, would support a
multimorbidity-based approach as advocated by the National Institute of Health and Care Excellence.
The use of patient-centred care focused around how one’s comorbidities and their treatments impact on
quality of life and how they align with their life priorities, emphasising strong care coordination [43].
These models are compatible with geriatric principles of care that have been advocated within the
HIV literature [11,44,45]. Patient-reported QoL was poor at baseline, with no significant change at
one year. This likely reflects the level of comorbidity and functional limitation, alongside unmeasured
psychosocial factors [46]. Whilst the former were addressed from a diagnostic perspective, service users
could benefit from broader MDT intervention, care coordination, and community-based intervention
centred on social prescribing and peer support [47].
It was gratifying to see that the survey of HCPs indicated appropriate awareness of the Silver Clinic,
with many reporting the positive improvement to the management of older PLWH as a consequence of
the clinic. However, a recent UK survey identified the existence of only two dedicated HIV-ageing
services nationwide, with two-thirds of respondents citing insufficient population as the reason for no
perceived need for such a service [48], yet we know that a predominantly older adult HIV population
is predicted in the near future [3]. HIV-ageing services are now being reported more widely, mainly in
high income settings, which are either based on geriatric syndromes or metabolic comorbidities in
PLWH [49]. Attendees reported high levels of satisfaction with the clinic, though it should be noted that
the number providing feedback was self-selecting and small (35%). However, service user feedback is
vital in both the development and evaluation of any new ageing services, with respondents in one
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survey favouring the maintenance of care within HIV settings, alongside enhanced communication
and care coordination [50].
To our knowledge, this represents the first evaluation of a UK-based joint HIV-ageing service run
on a needs- rather than age-based approach that utilises CGA principles. It is limited in its presentation
of single-site data that are purely descriptive in nature. Other limitations include the small sample
size, which also limits the generalizability and reproducibility of the data. Data presented here are
not able to define the longer-term benefit regarding preservation of function, admission avoidance,
and mortality, as well as the cost-effectiveness of attending the Silver Clinic. However, this is the case
for many new services, which are not, at present, being driven by a supporting evidence base. The role
of such a clinic, and in particular the role of CGA applied to individuals living with HIV, represents
areas of research need within HIV and ageing, which is supported by a nationwide service evaluation
on HIV-ageing services that identified a lack of evidence base as a barrier for service development [48].
However, the Silver Clinic is a trail-blazer for other services, with a model that, since conception, meets
the recommendations from both the 2019 EACS guidance on frailty screening in PLWH [51] and the
2018 British HIV Association Standards of Care document, which advocates the involvement of a
geriatrician with HIV knowledge in the care of service users requiring complex HIV care [52].
5. Conclusions
We have operationalised a dedicated HIV-ageing service founded on geriatric medicine principles
that is acceptable to both service users and referrers within HIV medicine. Referral pathways have
identified a clinic cohort with high burden of frailty, comorbidity, and geriatric syndromes that might
benefit from comprehensive geriatric assessment. Ongoing evaluation and research in this area is
crucial to demonstrate the effectiveness of this model of care and/or help in building an evidence base
to support other models of care for those ageing with HIV.
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